Corbus Pharmaceuticals Holdings Inc (CRBP.OQ)
CRBP.OQ on NASDAQ Stock Exchange Global Market
4.85USD
17 Aug 2018
4.85USD
17 Aug 2018
Change (% chg)
$0.05 (+1.04%)
$0.05 (+1.04%)
Prev Close
$4.80
$4.80
Open
$4.75
$4.75
Day's High
$4.90
$4.90
Day's Low
$4.75
$4.75
Volume
32,684
32,684
Avg. Vol
76,818
76,818
52-wk High
$9.85
$9.85
52-wk Low
$4.53
$4.53
About
Corbus Pharmaceuticals Holdings, Inc. is a Phase-III, clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company operates through developing and commercializing therapeutics to treat rare... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $371.63 |
| Shares Outstanding(Mil.): | 50.22 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CRBP.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 85.68 | 32.76 |
| EPS (TTM): | -0.60 | -- | -- |
| ROI: | -100.08 | 1.78 | 14.61 |
| ROE: | -100.21 | 3.28 | 16.33 |
BRIEF-Corbus Pharmaceuticals Reports Q1 Loss Per Share $0.21
* CORBUS PHARMACEUTICALS REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
BRIEF-Corbus Pharmaceuticals Reports 2017 Financial Results And Provides Clinical Update
* CORBUS PHARMACEUTICALS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES CLINICAL UPDATE
Competitors
| Price | Chg | |
|---|---|---|
| Roche Holding Ltd. (ROG.S) | CHF239.95 | +0.75 |
| Roche Holding Ltd. (RO.S) | CHF243.20 | +0.20 |
| Bristol-Myers Squibb Co (BMY.N) | $60.89 | -0.22 |
| Bristol-Myers Squibb Co (BMYMP.PK) | $999.90 | -- |
| Sanofi SA (SASY.PA) | €73.30 | +0.64 |
| PTC Therapeutics, Inc. (PTCT.OQ) | $42.35 | -0.34 |
| Novartis AG (NOVN.S) | CHF82.48 | +0.76 |
| Bayer AG (BAYGn.DE) | €78.40 | +1.35 |
| Bayer AG (BAYE.F) | -- | -- |
| Galapagos NV (GLPG.AS) | €88.72 | -1.22 |
Estimates